Bioactive Granular Hydrogel Scaffolds for Light-Free Regeneration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing hydrogel scaffolds require light exposure for crosslinking, limiting their use in tissues without access to light and hindering noninvasive or minimally invasive tissue regeneration.

Innovation Solution

Forming hydrogel microparticles via chemical crosslinking and assembling them using orthogonal, non-light-mediated methods, allowing for the creation of stable granular hydrogel scaffolds that can be injected into tissues and assemble without light exposure, incorporating biologics and mimicking native tissue characteristics.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If light-mediated crosslinking is used to form hydrogel scaffolds, then crosslinking efficiency and scaffold stability are improved, but applicability to tissues without light access and minimally invasive procedures deteriorates

Engineering Contradiction:
Improvescaffold stabilityVSAvoidapplicability to dark tissues
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent replaces light-mediated crosslinking (optical/chemical system) with enzyme-mediated crosslinking (biological system). Microgels are functionalized with enzyme substrates that, when exposed to specific enzymes in the target tissue, trigger crosslinking and scaffold formation without requiring light exposure. This enables scaffold formation in dark or deep tissues while maintaining structural stability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces enzymes as intermediary agents that mediate the crosslinking process. The microgels contain enzyme substrates (e.g., peptide sequences) that serve as intermediaries between the microgel particles and the crosslinking reaction. When enzymes encounter these substrates in the target tissue, they catalyze the crosslinking reaction, enabling scaffold formation without direct light exposure.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If open surgery is used to implant hydrogel scaffolds, then scaffold placement precision is improved, but invasiveness and patient morbidity worsens

Engineering Contradiction:
Improvescaffold placement precisionVSAvoidinvasiveness
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The patent divides the scaffold into numerous small microgels (1-100 micrometers) that can be injected as a suspension through minimally invasive routes. The microgels maintain individual stability but can self-assemble into a cohesive scaffold structure in situ, combining the benefits of minimally invasive delivery with precise scaffold placement.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent performs preliminary functionalization of microgels with enzyme substrates and crosslinkable groups before injection. This preliminary preparation enables the microgels to automatically crosslink and form a stable scaffold structure once they reach the target tissue and encounter the appropriate enzymes, eliminating the need for surgical implantation while ensuring precise placement.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If complex multi-step crosslinking is used to form stable scaffolds, then scaffold stability is improved, but process complexity and time required worsens

Engineering Contradiction:
Improvescaffold stabilityVSAvoidprocess complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent combines multiple crosslinking mechanisms into a unified enzyme-mediated process. Microgels are functionalized with both enzyme substrates and crosslinkable groups that work together in a single enzymatic reaction step. The enzyme catalyzes both the recognition/binding of microgels and the crosslinking reaction simultaneously, simplifying the process while maintaining scaffold stability.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables noninvasive or minimally invasive tissue regeneration by forming stable hydrogel scaffolds that enhance cell infiltration, viability, and tissue integration, promoting vascularization and tissue function improvement without open surgery.

Implementation Method 1

a polymer can be converted to stable microgels (micro-scale hydrogel particles) via chemical crosslinking

Methodology Applied
Scientific EffectChemical crosslinking: Chemical Bonding

Implementation Method 2

followed by microgel-microgel assembly using orthogonal, non-light-mediated crosslinking

Methodology Applied
Scientific EffectOrthogonal crosslinking: Chemical Bonding

Data Source

PatentUS20250270374A1Bioactive granular hydrogel scaffolds and use thereof
Publication Date: 2025.08.28 THE PENN STATE RES FOUND INC
  • US20250270374A1 patent drawing
  • US20250270374A1 patent drawing
  • US20250270374A1 patent drawing

AI summary

Embodiments relate to porous hydrogel microparticles, porous granular hydrogel scaffolds, and methods of making and using thereof. A method of making porous hydrogel microparticles includes crosslinking first polymers and second polymers to form composite microgels, adding the composite microgels to a liquid solution at a first temperature to form a composite microgel suspension, reducing the temperature of the composite microgel suspension to a second temperature below a phase separation temperature such that the second polymers separate from the first polymers, and filtering the composite microgel suspension from the liquid solution such that the second polymers diffuse out of the composite microgel suspension, resulting in the porous microgels.